Mission
TO FUND RESEARCH TO DISCOVER CURES AND MORE EFFECTIVE TREATMENTS FOR NEUROENDOCRINE CANCERS. THE NETRF IS COMMITTED TO IMPROVING THE LIVES OF THOSE AFFECTED BY NEUROENDOCRINE CANCER BY PROVIDING INFORMATION & EDUCATIONAL RESOURCES.
Public Charity
NEUROENDOCRINE TUMOR RESEARCH FOUNDATION
NEUROENDOCRINE TUMOR RESEARCH FOUNDATION is a nonprofit organization categorized as Public Charity based in QUINCY, MA. Its most recent IRS filing (2025) reports revenue of $8.7M, expenses of $4.8M, total assets of $27.6M. Imperigo tracks 74 reported grant relationships connected to this organization totaling approximately $3.8M.
EIN: 201945347
QUINCY, MA
Fund Raising & Fund Distribution
NTEE: G12
Latest filing: 2025
Total Revenue$8.7M
Total Expenses$4.8M
Total Assets$27.6M
Grant Records74
Funding Total$3.8M
Filing Years2021–2025
Where $100 goes at Neuroendocrine Tumor Research Foundation
How Neuroendocrine Tumor Research Foundation divides every $100 it spends, from its own Form 990 filings, averaged across 7 years.
$85
Programs
the work itself
$6
Management
running the organization
$9
Fundraising
raising the next dollar
Inside the $85 for programs
$74
The Neuroendocrine Tumor Research Foundation funds scientific research around the world to discover the causes, improve treatments, and find cures for neuroendocrine cancer
$9
Netrf provides education and support for people with neuroendocrine cancer and their families
$2
Netrf conducts outreach to other net-related organizations in the united states and beyond to convene researchers and facilitate scientific collaboration
Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
GENERAL SUPPORT
$7,051
GENERAL SUPPORT
$6,800
For grant recipient's exempt purposes
$357,975
PROVIDE GENERAL OPERATING SUPPORT
$250,000
$131,906
Showing up to 5 of 74 total records — full history available with membership.
Officers & Directors
DIRECTOR OF RESEARCH
Anna Greene
DIRECTOR
Anthony Detre
DIRECTOR
Carrie Camino
DIRECTOR
Elaine Nord As Of 492025
CHIEF EXECUTIVE OFFICER
Elyse Gellerman
DIRECTOR OF PATIENT EDUCATION
Jessica Thomas
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $8.7M | $4.8M | $27.6M |
| 2024 | $4.0M | $3.8M | $21.4M |
| 2023 | $3.2M | $3.6M | $20.6M |
| 2022 | $3.1M | $3.5M | $20.5M |
| 2021 | $8.2M | $5.4M | $26.6M |
Between 2021 and 2025, reported annual revenue grew from $8.2M to $8.7M (+6%), with total assets most recently reported at $27.6M.
Interactive year-over-year charts and full filing details available with membership.